NeueHealth (NEUE) Notifies Removal from NYSE in Form 25

NeueHealth, Inc. submitted a Form 25 notification relating to the removal of its securities from listing and/or registration on the New York Stock Exchange LLC.

Rhea-AI Filing Summary

NeueHealth, Inc. submitted a Form 25 notification relating to the removal of its securities from listing and/or registration on the New York Stock Exchange LLC. The filing identifies the issuer's principal office in Minneapolis, MN and states the Exchange and the Issuer have complied with the procedural requirements under 17 CFR 240.12d2-2 for striking the class of securities from listing and/or for voluntary withdrawal. No financial results, transaction details, or dates of effectiveness are provided in the text supplied.

Positive

• Exchange and Issuer compliance with 17 CFR 240.12d2-2 procedural requirements

Negative

• Securities removal from listing on the New York Stock Exchange LLC (delisting/withdrawal)

Insights

Corporate Governance Specialist

Form 25 notifies market that NEUE will be removed from NYSE; procedural compliance is stated.

The filing explicitly identifies the issuer as NeueHealth, Inc. and the Exchange as the New York Stock Exchange LLC, and it states both the Exchange and the Issuer complied with 17 CFR 240.12d2-2. This confirms the delisting/withdrawal followed required procedural steps rather than indicating an enforcement action.

Because the document contains no effective date, trading status after removal, or plan for alternative quotation venues, those investor‑relevant details are not available in this filing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 25 for NeueHealth, Inc. (NEUE) state?

The filing notifies the removal of NeueHealth, Inc.'s securities from the New York Stock Exchange LLC and states the Exchange and Issuer complied with 17 CFR 240.12d2-2.

Does the filing include an effective delisting date for NEUE?

No. The provided text does not include an effective date or timeline for the removal.

Does the Form 25 disclose financial results or transactions for NEUE?

No. The filing contains no earnings, transaction amounts, or other financial data.

Does the Form 25 indicate whether the delisting is voluntary or involuntary?

The form references compliance with provisions covering both exchange-initiated and voluntary withdrawals, but the document does not clearly state which specific provision was relied upon.

Where is NeueHealth, Inc.'s principal executive office listed in the filing?

The filing lists the principal executive office at 8000 Norman Center Drive, Suite 900, Minneapolis, MN 55437 and a telephone number of 612-238-1321.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/02/2025 - 09:38 AM Learn about SEC filing dates

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-40537

Issuer:	NeueHealth, Inc.
Exchange:	NEW YORK STOCK EXCHANGE LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	8000 Norman Center Drive, Suite 900
	Minneapolis	MINNESOTA	55437
Telephone number:					612-238-1321

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Common Stock

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, NEW YORK STOCK EXCHANGE LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2025-10-02	By	Tyler Mastronardi		Analyst, Market Watch
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.